<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Comprehensive Survival Power Analysis (Expert) — comprehensiveSurvivalPower • ClinicoPath</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Comprehensive Survival Power Analysis (Expert) — comprehensiveSurvivalPower"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">ClinicoPath</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.0.32.72</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="nav-item"><a class="nav-link" href="../dev/index.html"><span class="fa fa-cogs"></span></a></li>
<li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item"><a class="nav-link" href="../articles/index.html">Articles</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-test-data" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true"><span class="fa fa-database"></span> Test Data</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-test-data"><li><a class="dropdown-item" href="../articles/test-data-catalog.html">Test Data Catalog</a></li>
    <li><a class="dropdown-item" href="../articles/test-data-complete-catalog.html">Complete Catalog (945 files)</a></li>
    <li><a class="dropdown-item" href="../articles/function-reference.html">Function Reference</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><a class="external-link nav-link" href="http://twitter.com/serdarbalci"><span class="fa fab fa-twitter fa-lg"></span></a></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/sbalci/ClinicoPathJamoviModule/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>Comprehensive Survival Power Analysis (Expert)</h1>
      <small class="dont-index">Source: <a href="https://github.com/sbalci/ClinicoPathJamoviModule/blob/HEAD/R/comprehensiveSurvivalPower.h.R" class="external-link"><code>R/comprehensiveSurvivalPower.h.R</code></a></small>
      <div class="d-none name"><code>comprehensiveSurvivalPower.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">comprehensiveSurvivalPower</span><span class="op">(</span></span>
<span>  <span class="va">data</span>,</span>
<span>  method_category <span class="op">=</span> <span class="st">"standard"</span>,</span>
<span>  calculation_type <span class="op">=</span> <span class="st">"sample_size"</span>,</span>
<span>  statistical_method <span class="op">=</span> <span class="st">"log_rank_schoenfeld"</span>,</span>
<span>  study_design <span class="op">=</span> <span class="st">"simple"</span>,</span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.8</span>,</span>
<span>  sample_size <span class="op">=</span> <span class="fl">200</span>,</span>
<span>  allocation_ratio <span class="op">=</span> <span class="fl">1</span>,</span>
<span>  hazard_ratio <span class="op">=</span> <span class="fl">0.75</span>,</span>
<span>  median_survival_control <span class="op">=</span> <span class="fl">12</span>,</span>
<span>  median_survival_treatment <span class="op">=</span> <span class="fl">16</span>,</span>
<span>  accrual_period <span class="op">=</span> <span class="fl">24</span>,</span>
<span>  follow_up_period <span class="op">=</span> <span class="fl">36</span>,</span>
<span>  dropout_rate <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  event_rate <span class="op">=</span> <span class="fl">0.6</span>,</span>
<span>  competing_event_rate <span class="op">=</span> <span class="fl">0.2</span>,</span>
<span>  cumulative_incidence_control <span class="op">=</span> <span class="fl">0.4</span>,</span>
<span>  cumulative_incidence_treatment <span class="op">=</span> <span class="fl">0.3</span>,</span>
<span>  rmst_timepoint <span class="op">=</span> <span class="fl">24</span>,</span>
<span>  non_inferiority_margin <span class="op">=</span> <span class="fl">1.25</span>,</span>
<span>  superiority_test <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  snp_maf <span class="op">=</span> <span class="fl">0.2</span>,</span>
<span>  genetic_model <span class="op">=</span> <span class="st">"additive"</span>,</span>
<span>  number_of_looks <span class="op">=</span> <span class="fl">1</span>,</span>
<span>  spending_function <span class="op">=</span> <span class="st">"lan_demets_obf"</span>,</span>
<span>  show_detailed_output <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  show_sensitivity_analysis <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  show_power_curves <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  export_study_design <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  genetic_effect_size <span class="op">=</span> <span class="fl">1.5</span>,</span>
<span>  cure_rate_control <span class="op">=</span> <span class="fl">0</span>,</span>
<span>  cure_rate_treatment <span class="op">=</span> <span class="fl">0</span>,</span>
<span>  survival_distribution <span class="op">=</span> <span class="st">"exponential"</span>,</span>
<span>  accrual_distribution <span class="op">=</span> <span class="st">"uniform"</span>,</span>
<span>  interim_futility_boundary <span class="op">=</span> <span class="fl">0.2</span>,</span>
<span>  binding_futility <span class="op">=</span> <span class="cn">FALSE</span>,</span>
<span>  number_of_covariates <span class="op">=</span> <span class="fl">2</span>,</span>
<span>  covariate_correlation <span class="op">=</span> <span class="fl">0</span>,</span>
<span>  interaction_effect_size <span class="op">=</span> <span class="fl">1</span>,</span>
<span>  covariate_distribution <span class="op">=</span> <span class="st">"normal"</span>,</span>
<span>  adjust_for_confounders <span class="op">=</span> <span class="cn">TRUE</span>,</span>
<span>  show_method_comparison <span class="op">=</span> <span class="cn">FALSE</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-data">data<a class="anchor" aria-label="anchor" href="#arg-data"></a></dt>
<dd><p>The data as a data frame (optional for power calculations).</p></dd>


<dt id="arg-method-category">method_category<a class="anchor" aria-label="anchor" href="#arg-method-category"></a></dt>
<dd><p>Choose the category of survival analysis method.
Standard methods include log-rank tests and Cox regression. Competing risks
methods analyze multiple event types. Advanced methods include RMST,
non-inferiority, and specialized approaches.</p></dd>


<dt id="arg-calculation-type">calculation_type<a class="anchor" aria-label="anchor" href="#arg-calculation-type"></a></dt>
<dd><p>Select what parameter to calculate. Most commonly
used are sample size (given desired power) and power (given available
sample size).</p></dd>


<dt id="arg-statistical-method">statistical_method<a class="anchor" aria-label="anchor" href="#arg-statistical-method"></a></dt>
<dd><p>Choose the specific statistical method. Available
options depend on the selected method category. Schoenfeld method is most
common for log-rank tests.</p></dd>


<dt id="arg-study-design">study_design<a class="anchor" aria-label="anchor" href="#arg-study-design"></a></dt>
<dd><p>Simple design assumes fixed follow-up time. Complex
design includes accrual period and variable follow-up. Sequential designs
allow interim analyses.</p></dd>


<dt id="arg-alpha">alpha<a class="anchor" aria-label="anchor" href="#arg-alpha"></a></dt>
<dd><p>Type I error rate. Standard values: 0.05 (two-sided) or 0.025
(one-sided). For non-inferiority trials, consider 0.025.</p></dd>


<dt id="arg-power">power<a class="anchor" aria-label="anchor" href="#arg-power"></a></dt>
<dd><p>Statistical power (probability of detecting true effect).
Standard values: 0.80 (80\<!-- %) or 0.90 (90\\%). Higher power requires larger -->
sample sizes.</p></dd>


<dt id="arg-sample-size">sample_size<a class="anchor" aria-label="anchor" href="#arg-sample-size"></a></dt>
<dd><p>Total number of subjects in the study. Used when
calculating power or detectable effect size from a fixed sample size.</p></dd>


<dt id="arg-allocation-ratio">allocation_ratio<a class="anchor" aria-label="anchor" href="#arg-allocation-ratio"></a></dt>
<dd><p>Ratio of control to treatment group sizes. 1.0 =
equal allocation (1:1), 2.0 = twice as many controls (2:1). Equal
allocation is most efficient.</p></dd>


<dt id="arg-hazard-ratio">hazard_ratio<a class="anchor" aria-label="anchor" href="#arg-hazard-ratio"></a></dt>
<dd><p>Expected hazard ratio. Values &lt; 1 indicate treatment
benefit. Common values: 0.75 (25\<!-- % reduction), 0.67 (33\\% reduction), 0.50 -->
(50\<!-- % reduction).} --></p>
<p>median_survival_controlExpected median survival time in control
group. Units should match your study timeline (months, years, etc.).</p>
<p>median_survival_treatmentExpected median survival time in treatment
group. Should be longer than control group for beneficial treatments.</p>
<p>accrual_periodTime period for patient recruitment (months/years).
Longer accrual periods allow for smaller sample sizes but extend study
duration.</p>
<p>follow_up_periodAdditional follow-up time after accrual completion.
Total study duration = accrual period + follow-up period.</p>
<p>dropout_rateAnnual rate of loss to follow-up (0.05 = 5\<!-- % per year). -->
Higher dropout rates require larger sample sizes to maintain power.</p>
<p>event_rateProportion of subjects expected to experience the event
during study period. Used for simple design calculations.</p>
<p>competing_event_rateProportion experiencing competing events (for
competing risks analysis). Should be less than primary event rate.</p>
<p>cumulative_incidence_controlExpected cumulative incidence of
primary event in control group (for competing risks analysis).</p>
<p>cumulative_incidence_treatmentExpected cumulative incidence of
primary event in treatment group (for competing risks analysis).</p>
<p>rmst_timepointTime point for restricted mean survival time
analysis. Should be clinically meaningful and within study follow-up
period.</p>
<p>non_inferiority_marginNon-inferiority margin for hazard ratio. 1.25
means treatment is non-inferior if HR &lt; 1.25 (25\<!-- % increase in hazard is -->
acceptable).</p>
<p>superiority_testAfter establishing non-inferiority, test for
superiority. Requires hierarchical testing approach to control Type I
error.</p>
<p>snp_mafMinor allele frequency for SNP-based survival analysis.
Common range: 0.05-0.45.</p>
<p>genetic_modelGenetic inheritance model for SNP analysis. Additive
model is most common.</p>
<p>number_of_looksNumber of planned interim analyses for sequential
designs. More looks require larger sample sizes to maintain overall Type I
error.</p>
<p>spending_functionMethod for spending Type I error across interim
analyses. O'Brien-Fleming type preserves most alpha for final analysis.</p>
<p>show_detailed_outputDisplay detailed calculation steps and
intermediate results.</p>
<p>show_sensitivity_analysisPerform sensitivity analysis varying key
parameters around their specified values (+/- 10\<!-- %, 20\\%).} -->show_power_curvesGenerate plots showing power vs sample size,
effect size, or other parameters.export_study_designGenerate a comprehensive study design document
suitable for protocols and grant applications.genetic_effect_sizeGenetic effect size for SNP-based survival
analysis. Represents the hazard ratio per copy of the risk allele.cure_rate_controlProportion of subjects in control group who will
never experience the event (cure fraction). 0 = no cure, standard survival
model.cure_rate_treatmentProportion of subjects in treatment group who
will never experience the event (cure fraction). Usually higher than
control group in effective treatments.survival_distributionAssumed underlying survival distribution.
Exponential assumes constant hazard; Weibull allows increasing/decreasing
hazard; Piecewise allows complex patterns.accrual_distributionPattern of patient enrollment over time.
Uniform = constant rate; Increasing/Decreasing = linear change; Exponential
= curved pattern.interim_futility_boundaryFutility boundary for interim analyses in
sequential designs. Probability threshold below which study may be stopped
for futility.binding_futilityWhether futility boundaries are binding (must stop
if crossed) or non-binding (advisory only).number_of_covariatesNumber of covariates to include in the Cox
regression model. More covariates generally require larger sample sizes.covariate_correlationCorrelation between covariates in the model.
Higher correlation reduces effective sample size and increases required
sample size.interaction_effect_sizeEffect size for interaction between main
exposure and other covariates. Used when testing interaction effects.covariate_distributionDistribution type for covariates in the
model. Affects power calculations for epidemiological studies.adjust_for_confoundersWhether to account for confounding variables
in power calculations. Generally recommended for epidemiological studies.show_method_comparisonCompare results across multiple power
calculation methods to assess robustness of sample size estimates.


A results object containing:
</p><table class="table table"><tr><td><code>results$instructions</code></td><td></td><td></td><td></td><td></td><td>a html</td></tr><tr><td><code>results$powerResults</code></td><td></td><td></td><td></td><td></td><td>a table</td></tr><tr><td><code>results$methodDetails</code></td><td></td><td></td><td></td><td></td><td>a table</td></tr><tr><td><code>results$studyDesign</code></td><td></td><td></td><td></td><td></td><td>a html</td></tr><tr><td><code>results$assumptions</code></td><td></td><td></td><td></td><td></td><td>a table</td></tr><tr><td><code>results$sensitivityTable</code></td><td></td><td></td><td></td><td></td><td>a table</td></tr><tr><td><code>results$powerCurvePlot</code></td><td></td><td></td><td></td><td></td><td>an image</td></tr><tr><td><code>results$effectSizePlot</code></td><td></td><td></td><td></td><td></td><td>an image</td></tr><tr><td><code>results$methodComparison</code></td><td></td><td></td><td></td><td></td><td>a table</td></tr><tr><td><code>results$competingRisksDetails</code></td><td></td><td></td><td></td><td></td><td>a table</td></tr><tr><td><code>results$sequentialDesign</code></td><td></td><td></td><td></td><td></td><td>a table</td></tr><tr><td><code>results$clinicalInterpretation</code></td><td></td><td></td><td></td><td></td><td>a html</td></tr><tr><td><code>results$protocolSummary</code></td><td></td><td></td><td></td><td></td><td>a html</td></tr><tr><td><code>results$regulatoryNotes</code></td><td></td><td></td><td></td><td></td><td>a html</td></tr><tr><td><code>results$technicalDetails</code></td><td></td><td></td><td></td><td></td><td>a html</td></tr></table>Tables can be converted to data frames with <code>asDF</code> or <code><a href="https://rdrr.io/r/base/as.data.frame.html" class="external-link">as.data.frame</a></code>. For example:<code>results$powerResults$asDF</code><code>as.data.frame(results$powerResults)</code>


Comprehensive power analysis and sample size calculation for survival
studies and clinical trials. Unifies all survival power methods: standard
log-rank tests, Cox regression, competing risks, RMST-based analyses,
non-inferiority trials, and specialized methods. Supports both simple and
complex study designs with accrual periods, variable follow-up, and dropout
considerations. Essential for study planning, grant applications, and
regulatory submissions.


# Standard log-rank test power calculation
comprehensiveSurvivalPower(
    method_category = "standard",
    calculation_type = "sample_size",
    statistical_method = "log_rank",
    hazard_ratio = 0.75,
    power = 0.80,
    alpha = 0.05,
    allocation_ratio = 1
)# Competing risks power analysis
comprehensiveSurvivalPower(
    method_category = "competing_risks",
    calculation_type = "power",
    statistical_method = "grays_test",
    sample_size = 300,
    effect_size = 0.15,
    alpha = 0.05
)# Advanced RMST-based analysis
comprehensiveSurvivalPower(
    method_category = "advanced",
    calculation_type = "effect_size",
    statistical_method = "rmst",
    sample_size = 400,
    power = 0.90,
    alpha = 0.05,
    rmst_timepoint = 24
)</dd>

</dl></div>

  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by <a href="https://www.serdarbalci.com/" class="external-link">Serdar Balci</a>.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer></div>





  </body></html>

